Mergers and Acquisitions

Elan shareholders approved a share buyback that means Royalty Pharma's hostile bid for the Irish drug firm could lapse.

The airliner will add 35 Airbus A350-1000 long-distance aircraft to its fleet, increasing its original order.

The world's largest pork producer suffered a steep contraction in earnings due to rising costs.

The European Commission is expected to give Delta unconditional European regulatory approval to buy a 49% stake in Virgin Atlantic.

The biopharmaceutical business is buying privately-held Pearl Therapeutics for up to $1.15 billion to build its portfolio of respiratory disease drugs.

The biopharmaceutical business is buying privately-held Pearl Therapeutics for up to $1.15 billion to build its portfolio of respiratory disease drugs.

The biopharmaceutical business is buying privately-held Pearl Therapeutics for up to $1.15 billion to build its portfolio of respiratory disease drugs.

Shuanghui International Holdings Ltd has mandated Bank of China for an up to $4 billion global syndicated financing to support its acquisition of Smithfield Foods.

The global biopharmaceutical business has entered into a definitive agreement to buy Omthera Pharmaceuticals in a deal valued at $323 million.

The global biopharmaceutical business has entered into a definitive agreement to buy Omthera Pharmaceuticals in a deal valued at $323 million.

Shareholders of medical device maker Medtronic on Tuesday approved the acquisition of Dublin, Ireland-based surgical supplier Covidien PLC in a corporate deal valued at about $48 billion.

Pfizer continued its aggressive push into the development of new vaccines, announcing the acquisition of a controlling stake in Switzerland's Redvax GmbH on Monday.